scholarly article | Q13442814 |
P50 | author | Agnes Görlach | Q97309728 |
P2093 | author name string | Maximilian Burger | |
John Hess | |||
Isabel Diebold | |||
Andreas Petry | |||
P2860 | cites work | Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase | Q24310456 |
Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin | Q24311484 | ||
Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues | Q24532085 | ||
Is urotensin-II the new endothelin? | Q24672927 | ||
Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-kappaB pathway | Q28270955 | ||
The FoxO code | Q28275268 | ||
Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site | Q28286400 | ||
FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription | Q28566755 | ||
DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein | Q28577209 | ||
Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells | Q28582797 | ||
Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a | Q28592736 | ||
FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis | Q33604706 | ||
MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study | Q33820443 | ||
The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. | Q33907086 | ||
Matrix metalloproteinases: they're not just for matrix anymore! | Q34360566 | ||
Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells | Q34379685 | ||
Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia | Q34603743 | ||
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation | Q35770614 | ||
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease | Q36477722 | ||
Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. | Q36755423 | ||
Dynamic FoxO transcription factors | Q36889897 | ||
Urotensin-II and cardiovascular remodeling | Q36995672 | ||
FoxO proteins: cunning concepts and considerations for the cardiovascular system | Q37195595 | ||
FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. | Q37334058 | ||
Matrix metalloproteinases in atherothrombosis. | Q37708600 | ||
Role of urotensin II in health and disease | Q37737495 | ||
Forkhead homeobox type O transcription factors in the responses to oxidative stress | Q37771334 | ||
Structural basis for DNA recognition by FOXO proteins | Q37819155 | ||
The complex biology of FOXO. | Q37858545 | ||
FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms | Q38346760 | ||
NOX2 and NOX4 mediate proliferative response in endothelial cells. | Q40229689 | ||
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. | Q40398942 | ||
FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. | Q40493379 | ||
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization | Q42130997 | ||
Urotensin II is raised in children with congenital heart disease | Q42833174 | ||
Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase | Q43633744 | ||
Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase-2 (MMP-2) via NAD(P)H Oxidase–Derived Reactive Oxygen Species | Q44443254 | ||
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes | Q46402217 | ||
Critical role of Mst1 in vascular remodeling after injury. | Q46551613 | ||
Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes | Q46703588 | ||
Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases. | Q52583886 | ||
Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. | Q53670501 | ||
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension | Q61895228 | ||
Ca(2+)-dependent Cl(-) channels in mouse and rabbit aortic smooth muscle cells: regulation by intracellular Ca(2+) and NO | Q73188696 | ||
Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2: role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion | Q74211090 | ||
Isolation of vascular smooth muscle cells from a single murine aorta | Q78675064 | ||
Urotensin-II in the lung: a matter for vascular remodelling and pulmonary hypertension? | Q79828440 | ||
Human urotensin II modulates collagen synthesis and the expression of MMP-1 in human endothelial cells | Q80908840 | ||
From worm to human: bioinformatics approaches to identify FOXO target genes | Q81176620 | ||
Deciphering the "matrix" in pulmonary vascular remodelling | Q81702646 | ||
Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease | Q83912518 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 22 | |
P304 | page(s) | 4424-4434 | |
P577 | publication date | 2011-09-30 | |
P1433 | published in | Molecular Biology of the Cell | Q2338259 |
P1476 | title | NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II | |
P478 | volume | 22 |
Q89697823 | Early Programming of Adult Systemic Essential Hypertension |
Q39178512 | Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells |
Q39385262 | FOXO transcription factors at the interface of metabolism and cancer |
Q50077490 | FOXO3a (Forkhead Transcription Factor O Subfamily Member 3a) Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis, and Vascular Remodeling Through a Novel Pathway Involving MMP13 (Matrix Metalloproteinase 13). |
Q35559300 | Fad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity |
Q57823589 | Increasing autophagy does not affect neurogenic muscle atrophy |
Q91259885 | Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
Q38596162 | NADPH oxidases-do they play a role in TRPC regulation under hypoxia? |
Q36218362 | Oxidative Stress Induces Mouse Follicular Granulosa Cells Apoptosis via JNK/FoxO1 Pathway |
Q58073566 | Partial mitigation of gold nanoparticle interactions with human lymphocytes by surface functionalization with a ‘mixed matrix’ |
Q37334463 | Polymerase delta interacting protein 2 sustains vascular structure and function. |
Q34097015 | Polymerase δ-interacting protein 2 promotes postischemic neovascularization of the mouse hindlimb |
Q36587602 | Reactive oxygen species in vascular formation and development |
Q64060576 | Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension |
Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
Q39195350 | The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system |
Q28085161 | The role of oxidative stress and autophagy in atherosclerosis |
Q35014906 | Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway |
Q50796108 | Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. |
Q89338823 | p47phox-Dependent Reactive Oxygen Species Stimulate Nuclear Translocation of the FoxO1 Transcription Factor During Metabolic Inhibition in Cardiomyoblasts |
Search more.